lenacapavir yeztugo - Search News

News

FDA approves Yeztugo

FDA approves Yeztugo: Gilead's new twice-yearly HIV prevention injection

He affirmed that the new drug "could take the epidemic to the history books," according to Mother Jones.Yeztugo, based on the molecule lenacapavir, offers a more effective and less invasive prevention method,

CBS News on MSN · 2d

HIV prevention drug lenacapavir approved by FDA as twice-yearly injection

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo from company Gilead Sciences, remained HIV negative.

Wired · 1d

The FDA Just Approved a Long-Lasting Injection to Prevent HIV

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming infected with HIV. But big questions remain over the drug’s affordability.

17m

NIH office to phase out HIV guidelines by next year

The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...

Public Broadcasting Service (PBS)20h

6 things to know about lenacapavir, what experts call a ‘wonder drug’ for preventing HIV

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...

Managed Healthcare Executive2d

Lenacapavir HIV PrEP: Not an AIDS Vaccine, but Vaccine Adjacent

Experts and advocates say that twice-a-year HIV PrEP injections have the prevention potential of a vaccine — and that a once-a-year version of lenacapavir would be even better. But will Yeztugo be ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results